Data / Public companies / Medicinal chemicals and botanical products
Medicinal chemicals and botanical products (SIC 2833): 40 companies that file annual reports with the SEC
Updated September 30, 2026. Source: SEC Financial Statement Data Sets (sec.gov).
40 companies that file annual reports with the SEC have the industry code SIC 2833 (Medicinal chemicals and botanical products), in the data filed through September 30, 2026. 30 report revenue, a combined $7.02 billion, with a median of $58.1 million. 17.6% of the 34 that report net income show a profit. The largest by revenue is Curaleaf Holdings, Inc. ($1.27 billion).
The request: Get every company that files with the SEC in the industry Medicinal chemicals and botanical products (SIC 2833), with its revenue, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.
- SIC code
- 2833
- SEC industry title
- Medicinal Chemicals & Botanical Products
- Division
- Manufacturing
- Companies with an annual report in the data
- 40
- Companies that report revenue
- 30
- Combined revenue
- $7.02 billion
- Median revenue
- $58.1 million
- Reported a net profit
- 6 of 34 (17.6%)
- Combined total assets
- $14.04 billion
- Large accelerated filers
- 3
- Newest annual report filed
- September 28, 2026
Largest by revenue
Latest fiscal year, from each company's annual report. Each name links to the company's page.
| Company | Business address | Revenue | Net income | Total assets | Revenue change |
|---|---|---|---|---|---|
| Curaleaf Holdings, Inc. | New York, NY | $1.27 billion | $-231,070,000 | $2.85 billion | -5% |
| Trulieve Cannabis Corp. | Tallahassee, FL | $1.18 billion | $-122,248,000 | $2.70 billion | -0.4% |
| USANA Health Sciences Inc | Salt Lake City, UT | $925.3 million | $10.8 million | $742.9 million | 8.3% |
| Tilray Brands, Inc. | New York, NY | $915.5 million | $-121,397,000 | $2.33 billion | 11.5% |
| Cresco Labs Inc. | Chicago, IL | $655.8 million | $-135,408,000 | $1.20 billion | -9.5% |
| Ascend Wellness Holdings, Inc. | Morristown, NJ | $500.6 million | $-118,193,000 | $907.9 million | -10.9% |
| Jushi Holdings Inc. | Boca Raton, FL | $262.9 million | $-68,591,000 | $422.3 million | 2.1% |
| Biote Corp. | Irving, TX | $192.2 million | $27 million | $107.6 million | -2.5% |
| Glass House Brands Inc. | Long Beach, CA | $182 million | $-29,659,000 | $318.6 million | -9.4% |
| Marimed Inc. | Norwood, MA | $159.8 million | $-14,484,000 | $202.6 million | 1.3% |
| Cronos Group Inc. | Stayner, Canada | $146.6 million | $-9,447,000 | $1.20 billion | 24.6% |
| Natural Alternatives International Inc | Carlsbad, CA | $142.5 million | $-20,695,000 | $126.4 million | 9.7% |
| Niagen Bioscience, Inc. | Los Angeles, CA | $129.4 million | $17.4 million | $106.4 million | 29.9% |
| Mannatech Inc | Flower Mound, TX | $108 million | $-15,213,000 | $30 million | -8.3% |
| Fitlife Brands, Inc. | Omaha, NE | $81.5 million | $6.3 million | $106.3 million | 26.4% |
| Leef Brands Inc. | Vancouver | $34.8 million | $-17,629,675 | $36.4 million | 22.1% |
| C21 Investments Inc. | Vancouver | $32.6 million | $-3,243,718 | $54.4 million | 8.3% |
| Synergy CHC Corp. | Westbrook, ME | $30.4 million | $-12,341,208 | $10.2 million | -12.8% |
| Charlie's Holdings, Inc. | Costa Mesa, CA | $20.9 million | $4.5 million | $11.6 million | 169.4% |
| Bon Natural Life LTD | Shaanxi, China | $18.7 million | $-1,994,768 | $85.2 million | -21.7% |
| Twinlab Consolidated Holdings, Inc. | Boca Raton, FL | $11.7 million | $-9,499,000 | $6 million | -14.3% |
| Functional Brands Inc. | West Hollywood, CA | $6.6 million | $758,478 | $9.1 million | 0.7% |
| Healthy Extracts Inc. | Henderson, NV | $4.5 million | $-881,119 | $27.8 million | 44.9% |
| Target Group Inc. | Hamilton | $3.9 million | $-1,359,682 | $6.2 million | -41.1% |
| Cordyceps Sunshine Biotech Holdings Co., LTD. | Taipei City, Taiwan | $1.2 million | $-154,822 | $4.7 million | -0.6% |
Largest by total assets
| Company | Business address | Revenue | Net income | Total assets |
|---|---|---|---|---|
| Curaleaf Holdings, Inc. | New York, NY | $1.27 billion | $-231,070,000 | $2.85 billion |
| Trulieve Cannabis Corp. | Tallahassee, FL | $1.18 billion | $-122,248,000 | $2.70 billion |
| Tilray Brands, Inc. | New York, NY | $915.5 million | $-121,397,000 | $2.33 billion |
| Cresco Labs Inc. | Chicago, IL | $655.8 million | $-135,408,000 | $1.20 billion |
| Cronos Group Inc. | Stayner, Canada | $146.6 million | $-9,447,000 | $1.20 billion |
| Ascend Wellness Holdings, Inc. | Morristown, NJ | $500.6 million | $-118,193,000 | $907.9 million |
| USANA Health Sciences Inc | Salt Lake City, UT | $925.3 million | $10.8 million | $742.9 million |
| Definium Therapeutics, Inc. | New York, NY | Not listed | $-183,793,000 | $440.1 million |
| Jushi Holdings Inc. | Boca Raton, FL | $262.9 million | $-68,591,000 | $422.3 million |
| Glass House Brands Inc. | Long Beach, CA | $182 million | $-29,659,000 | $318.6 million |
| Marimed Inc. | Norwood, MA | $159.8 million | $-14,484,000 | $202.6 million |
| Natural Alternatives International Inc | Carlsbad, CA | $142.5 million | $-20,695,000 | $126.4 million |
| Biote Corp. | Irving, TX | $192.2 million | $27 million | $107.6 million |
| Niagen Bioscience, Inc. | Los Angeles, CA | $129.4 million | $17.4 million | $106.4 million |
| Fitlife Brands, Inc. | Omaha, NE | $81.5 million | $6.3 million | $106.3 million |
Companies by size of revenue
Companies that report revenue, by the revenue in their latest annual report.
| Revenue | Companies | Share |
|---|---|---|
| Under $10 million | 9 | 30% |
| $10 million to $100 million | 7 | 23.3% |
| $100 million to $1 billion | 12 | 40% |
| $1 billion to $10 billion | 2 | 6.7% |
States with the most companies
By state of the business address.
| State | Companies | Share | Combined revenue |
|---|---|---|---|
| California | 5 | 12.5% | $481.4 million |
| Florida | 5 | 12.5% | $1.46 billion |
| New York | 3 | 7.5% | $2.18 billion |
| Nevada | 2 | 5% | $4.5 million |
| Texas | 2 | 5% | $300.3 million |
| Georgia | 1 | 2.5% | $0 |
| Idaho | 1 | 2.5% | $2,183 |
| Illinois | 1 | 2.5% | $655.8 million |
| Massachusetts | 1 | 2.5% | $159.8 million |
| Maine | 1 | 2.5% | $30.4 million |
| Nebraska | 1 | 2.5% | $81.5 million |
| New Jersey | 1 | 2.5% | $500.6 million |
| Utah | 1 | 2.5% | $925.3 million |
Newest annual reports
By the date the company filed its latest annual report with the SEC.
| Company | Filed | Fiscal year ended | Form | Revenue |
|---|---|---|---|---|
| Natural Alternatives International Inc | September 28, 2026 | June 30, 2026 | 10-K | $142.5 million |
| Tilray Brands, Inc. | July 28, 2026 | May 31, 2026 | 10-K | $915.5 million |
| Canopy Growth Corp | June 15, 2026 | March 31, 2026 | 10-K | Not listed |
| C21 Investments Inc. | June 12, 2026 | March 31, 2026 | 20-F | $32.6 million |
| Aurora Cannabis Inc | June 11, 2026 | March 31, 2026 | 40-F | Not listed |
| Akanda Corp. | June 9, 2026 | December 31, 2025 | 20-F | Not listed |
| Nutra Pharma Corp | May 20, 2026 | December 31, 2025 | 10-K | $257,612 |
| Cordyceps Sunshine Biotech Holdings Co., LTD. | May 15, 2026 | December 31, 2025 | 20-F | $1.2 million |
| China Foods Holdings LTD. | April 16, 2026 | December 31, 2025 | 10-K | $327,871 |
| Aibotics, Inc. | April 15, 2026 | December 31, 2025 | 10-K | $2,183 |
| Mannatech Inc | April 15, 2026 | December 31, 2025 | 10-K | $108 million |
| Healthy Extracts Inc. | April 9, 2026 | December 31, 2025 | 10-K | $4.5 million |
Filer category
The SEC's size class for the company when it filed.
| Category | Companies | Share |
|---|---|---|
| Non-accelerated filer | 28 | 70% |
| Accelerated filer | 5 | 12.5% |
| Large accelerated filer | 3 | 7.5% |
Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.